[Empagliflozin also protects high risk patients].
.
Katharina
K
Arnheim
D006801:Humans; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000401:mortality; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000401:mortality; D004305:Dose-Response Relationship, Drug; D005960:Glucosides / Q000627:therapeutic use; D012307:Risk Factors; D015996:Survival Rate
D001559:Benzhydryl Compounds; C570240:empagliflozin; D005960:Glucosides